Evidence map›Paper›PMID 26216969›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Structural basis for inhibition of the histone chaperone activity of SET/TAF-Iβ by cytochrome c.

Katiuska González-Arzola, Irene Díaz-Moreno, Ana Cano-González, Antonio Díaz-Quintana, Adrián Velázquez-Campoy, Blas Moreno-Beltrán, Abelardo López-Rivas, Miguel A De la Rosa

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. CytochromeiScience · 2024
    Article
  5. The next decade of SET: from an oncoprotein to beyond.Journal of molecular cell biology · 2024
    Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Mitochondrial Factors in the Cell Nucleus.International journal of molecular sciences · 2023
    Review
  11. Article
  12. De novo sequencing and construction of a unique antibody for the recognition of alternative conformations of cytochromeProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. PP2A is activated by cytochromeComputational and structural biotechnology journal · 2022
    Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Katiuska González-ArzolaInstituto de Bioquímica Vegetal y Fotosíntesis (IBVF) - Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), Universidad de Sevilla - Consejo Superior de Investigaciones Científicas (CSIC), 41092 Sevilla, Spain;
Irene Díaz-MorenoInstituto de Bioquímica Vegetal y Fotosíntesis (IBVF) - Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), Universidad de Sevilla - Consejo Superior de Investigaciones Científicas (CSIC), 41092 Sevilla, Spain; marosa@us.es idiazmoreno@us.es.
Ana Cano-GonzálezCentro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER) - CSIC, 41092 Sevilla, Spain;
Antonio Díaz-QuintanaInstituto de Bioquímica Vegetal y Fotosíntesis (IBVF) - Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), Universidad de Sevilla - Consejo Superior de Investigaciones Científicas (CSIC), 41092 Sevilla, Spain;
Adrián Velázquez-CampoyInstituto de Biocomputación y Física de Sistemas Complejos (BIFI) - CSIC, 50018 Zaragoza, Spain; Departamento de Bioquímica y Biología Molecular y Celular, Universidad de Zaragoza, 50009 Zaragoza, Spain; Fundación Agencia Aragonesa para la Investigación y Desarrollo (ARAID), 50018 Zaragoza, Spain.
Blas Moreno-BeltránInstituto de Bioquímica Vegetal y Fotosíntesis (IBVF) - Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), Universidad de Sevilla - Consejo Superior de Investigaciones Científicas (CSIC), 41092 Sevilla, Spain;
Abelardo López-RivasCentro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER) - CSIC, 41092 Sevilla, Spain;
Miguel A De la RosaInstituto de Bioquímica Vegetal y Fotosíntesis (IBVF) - Centro de Investigaciones Científicas Isla de la Cartuja (cicCartuja), Universidad de Sevilla - Consejo Superior de Investigaciones Científicas (CSIC), 41092 Sevilla, Spain; marosa@us.es idiazmoreno@us.es.
Centro Andaluz de Biología Molecular y Medicina Regenerativa · ESCentro de Investigaciones Científicas Isla de la Cartuja · ESUniversidad de Sevilla · ESFundacion Agencia Aragonesa para la Investigacion y el Desarrollo · ESInstituto de Bioquímica Vegetal y Fotosíntesis · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromatin is pivotal for regulation of the DNA damage process insofar as it influences access to DNA and serves as a DNA repair docking site. Recent works identify histone chaperones as key regulators of damaged chromatin's transcriptional activity. However, understanding how chaperones are modulated during DNA damage response is still challenging. This study reveals that the histone chaperone SET/TAF-Iβ interacts with cytochrome c following DNA damage. Specifically, cytochrome c is shown to be translocated into cell nuclei upon induction of DNA damage, but not upon stimulation of the death receptor or stress-induced pathways. Cytochrome c was found to competitively hinder binding of SET/TAF-Iβ to core histones, thereby locking its histone-binding domains and inhibiting its nucleosome assembly activity. In addition, we have used NMR spectroscopy, calorimetry, mutagenesis, and molecular docking to provide an insight into the structural features of the formation of the complex between cytochrome c and SET/TAF-Iβ. Overall, these findings establish a framework for understanding the molecular basis of cytochrome c-mediated blocking of SET/TAF-Iβ, which subsequently may facilitate the development of new drugs to silence the oncogenic effect of SET/TAF-Iβ's histone chaperone activity.

Indexed as

AnimalsBinding, CompetitiveCamptothecinCell NucleusCytochromes cDNA-Binding ProteinsDNA DamageHeLa CellsHistone ChaperonesHistonesHumansMagnetic Resonance SpectroscopyModels, MolecularMolecular ChaperonesProtein BindingProtein Structure, TertiaryCamptothecinCytochromes cDNA-Binding ProteinsHistone ChaperonesHistonesMolecular ChaperonesSET protein, humanTranscription Factorscytochrome chistone chaperoneITCNMRSET-TAF-Iβ

Identifiers

PMID26216969
PMCPMC4538685
OpenAlexW1959985516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.